Add BrightSurf on Google Email

Science News for July 1, 2018


Does a full hospital mean higher infection risk?

Researchers found that hospital occupancy levels, particularly in the middle range, were associated with a lower risk of C. diff infections. When the hospital was between 25 percent and 75 percent full, the risk of infection was more than three times higher compared to less than 25 percent or more than 75 percent occupancy.

SourceMichigan Medicine - University of Michigan·JournalJournal of Hospital Medicine·DateJul 1, 2018

Gene discovery unlocks mysteries to our immunity

A team of researchers from CSIRO Australia has identified a new gene called C6 that regulates the body's immune response to infection and disease. The discovery could lead to targeted therapies for various diseases, including cancer, diabetes, and inflammatory disorders.

SourceCSIRO Australia·JournalJournal of Biological Chemistry·DateJul 1, 2018

Mindfulness is key to tinnitus relief research reveals

Researchers found Mindfulness based Cognitive Therapy (MBCT) significantly reduces tinnitus severity compared to relaxation-based treatments. MBCT teaches patients to 'allow' and 'accept' tinnitus, leading to a less intrusive experience.

SourceUniversity of Bath·JournalEar and Hearing·DateJul 1, 2018
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Predicting bad side effects

Researchers developed a DNA sequencing kit that identifies variations in the NUDT15 gene, allowing for accurate predictions of adverse reactions. The test has been approved for clinical use in Japan and holds promise for reducing severe side effects in East Asian patients.

SourceTohoku University·JournalJournal of Gastroenterology·DateJul 1, 2018

$20 blood test could help diagnose hepatitis B patients across Africa

Researchers developed an accurate diagnostic score that uses two simple blood tests to identify patients in need of treatment against the deadly hepatitis B virus. The test was found to be as accurate as existing methods but at a fraction of the cost, making it accessible for sub-Saharan Africa's poorest regions.

SourceImperial College London·JournalJournal of Hepatology·DateJul 1, 2018

Cost-effective universal screening for hepatitis C in France

A mathematical model developed by Sylvie Deuffic-Burban assesses the efficacy and cost-effectiveness of different screening strategies, including universal screening. The results show that universal screening is associated with better life expectancy adjusted for quality of life than other strategies.

SourceANRS·JournalJournal of Hepatology·DateJul 1, 2018